Article

Two case reports of childhood liver cell adenomas harboring beta-catenin abnormalities

Department of Pediatric Surgery, Tokyo University, Tokyo, Japan.
Human Pathlogy (Impact Factor: 2.81). 09/2002; 33(8):852-5. DOI: 10.1053/hupa.2002.125771
Source: PubMed

ABSTRACT The benign epithelial neoplasm liver cell adenoma is rare, especially in childhood. We report 2 such cases, 1 of which was associated with Prader-Willi syndrome. Differential diagnosis of the liver cell adenomas on the basis of histopathologic findings proved difficult and was based on the absence of cellular and nuclear atypia, mitotic activity, and invasive growth. In both cases, immunohistochemical staining demonstrated the nuclear accumulation of beta-catenin, and in 1 case, the tumor cells carried a mutation of the beta-catenin gene. Recently, disregulation of the Wnt/beta-catenin pathway, attributable to abnormalities of the beta-catenin gene, has been reported to be a major event in the development of hepatocellular carcinomas and hepatoblastomas. Our report may be the first to describe the beta-catenin abnormalities in childhood liver cell adenoma. These findings imply that abnormalities of beta-catenin can be an early initiating event in human liver tumorigenesis.

0 Followers
 · 
54 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hepatoblastoma (HB), the most common hepatic neoplasm in children is associated with germline mutations in adenomatous polyposis coli tumor-suppressor gene that cause familial adenomatous polyposis syndrome. Individuals with familial adenomatous polyposis have a 750 to 7500× the risk of developing HB. We report 3 children with APC gene mutation, who underwent resection or liver transplant for HB. In addition to HB, all 3 patients had multiple independent adenoma-like nodules lacking qualities of intrahepatic metastases. Twenty-five nodules were subjected to immunohistochemical analysis using a panel of antibodies including glypican-3 (GPC3), β-catenin, cytokeratin AE1/AE3, CD34, Ki-67, glutamine synthetase (GS), and fatty acid binding protein. The nodules were round, ranged in size from 0.2 to 1.5 cm, and paler than the background liver. All lacked the chemotherapy effect. The nodules were circumscribed but nonencapsulated and composed of well-differentiated hepatocytes with occasional minor atypical features and absent or rare portal tracts. One lesion displayed a "nodule-within-nodule" pattern. The nodules demonstrated diffuse GS overexpression. Nine (36%) nodules were focally reactive for GPC3, and 1 (4%) displayed focal nuclear β-catenin expression. The associated HB showed diffuse expression of GS, GPC3, and β-catenin nuclear staining. We interpret these nodules as neoplastic with most being adenomas (GPC3 negative) that show features of independent origin and represent early stages of carcinogenesis, implying potential to progress to HB or hepatocellular carcinoma. To our knowledge, this is the first report of multifocal neoplasms in patients with HB and APC gene mutation.
    The American journal of surgical pathology 05/2013; DOI:10.1097/PAS.0b013e31828aeb18 · 4.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Im Gegensatz zum hepatozellulren Karzinom (HCC) existierten bisher kaum molekularpathologische Untersuchungen des hepatozellulren Adenoms (HCA). Erkenntnisse zur Pathogenese liegen nur in Anstzen vor. Besonders von chirurgischer Seite wird eine Operationsindikation wegen einer mglichen malignen Entartung des HCA gestellt. Die publizierten Flle von bergngen von HCA in ein HCC wurden auf der Basis heutiger morphologischer Standards neu evaluiert. Auch erfolgte ein Vergleich neuer molekularpathologischer Untersuchungen des HCA – vor allem Arbeiten eigener Arbeitsgruppen – mit denen des HCC. Die Ergebnisse sprechen dagegen, dass es sich bei typischen solitren HCA prmenopausaler Frauen um eine Vorluferlsion des HCC handelt. Nach kritischer Revision der Literatur blieb nur eine Kasuistik eines bergangs HCA/HCC unter einer heute nicht mehr blichen Hormontherapie. Eine Abgrenzung besonderer HCA bei genetischen und Stoffwechselerkrankungen, Kindern, Mnnern, Adenomatosen und von HCA-artigen Tumoren bei bekannten Risikofaktoren des HCC erscheint sinnvoll. Bei den klassischen HCA dagegen knnte die onkologische chirurgische Indikation entfallen. Voraussetzung ist eine histologische Abklrung, ggf. mit Untersttzung durch molekularpathologische Methoden.In contrast to hepatocellular carcinoma (HCC), very few molecular pathological studies have been carried out on hepatocellular adenoma (HCA). Particularly from the surgical point of view, based on views passed on verbally and in the literature of the 1970s and 1980s, a possible degeneration of the HCA provides grounds for operating. Published cases of transitions from HCA into HCC were evaluated on the basis of todays morphological standards. A comparison was made between the patterns of new molecular pathological studies of HCA, above all the work of our own groups, and those of HCC. The results speak against the suggestion that a typical solitary HCA in pre-menopausal women is a precursor lesion of HCC. After a critical review of the literature, only one casuistic case of a transition of HCA to HCC under a hormone therapy, which is no longer practiced today, remained. A limitation of particular HCA in genetic and metabolic diseases, children, adult males, adenomatosis, and HCA-like tumors with known risk factors of HCC would seem pragmatically meaningful. With classic HCA, however, the oncological indication for surgery does not apply. A prerequisite is a histological clarification, if necessary with the support of molecular pathological methods.
    Der Pathologe 06/2006; 27(4):238-243. DOI:10.1007/s00292-006-0835-0 · 0.64 Impact Factor
  • 12/2004: pages 173-192;